Coenzyme
NAD+ (β-Nicotinamide Adenine Dinucleotide)
Clear nasal spray or white to off-white cream
Typical Strength
nasal 100–300 mg/mL; cream 0.5–1%
Formulations
1 compounds
Formula
C₂₁H₂₇N₇O₁₄P₂
Mol. Weight
663.4 g/mol
How It Works
Mechanism of action
Oxidized form of nicotinamide adenine dinucleotide, the coenzyme that carries electrons in cellular energy metabolism and supplies sirtuin and PARP enzymes. It is light-, heat- and moisture-sensitive, so it is kept refrigerated with a short beyond-use date.
What compounding can change
When NAD+ (β-Nicotinamide Adenine Dinucleotide) is compounded for one patient, your prescriber can choose the concentration, combine it with other ingredients, and pick the base. Commercial products come in fixed strengths and bases.
Safety Considerations
Available In
Formulations with NAD+ (β-Nicotinamide Adenine Dinucleotide)
Please note: Compounded medications require a prescription from a licensed prescriber for an individual patient. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality. A compounded medication is not the same as, or a generic version of, any FDA-approved drug. This page is general information, not medical advice. Your prescriber decides whether a treatment is right for you and sets the final ingredients, strength and dosage form.